The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma.
Authors: Rongrong Hui1,2, Xiulan Liu2, Zongyu Fan2, Honghai Ji1, Dongliang Wei2 weidongliang@sjtu.edu.cn, Guoxin Ren1,2,3,4 renguoxincn@sina.com
Source: Journal of Cancer. 2024, Vol. 15 Issue 6, p1668-1674. 7p.
Database: Academic Search Ultimate
Description
ISSN:18379664
DOI:10.7150/jca.92689